The impact of the time of drug administration on the effectiveness of combined treatment of hypercholesterolemia with Rosuvastatin and Ezetimibe (RosEze): study protocol for a randomized controlled trial

BACKGROUND: Hypercholesterolemia is one of the main risk factors for cardiovascular disease. The first line treatment for hypercholesterolemia is statin therapy. When the expected low-density lipoprotein cholesterol (LDL-C) concentration is not achieved, the pharmacotherapy may be extended by combin...

Descripción completa

Detalles Bibliográficos
Autores principales: Obońska, Karolina, Kasprzak, Michał, Sikora, Joanna, Obońska, Ewa, Racki, Krzysztof, Goździkiewicz, Natalia, Krintus, Magdalena, Kubica, Jacek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504756/
https://www.ncbi.nlm.nih.gov/pubmed/28697767
http://dx.doi.org/10.1186/s13063-017-2047-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504756/
https://www.ncbi.nlm.nih.gov/pubmed/28697767
http://dx.doi.org/10.1186/s13063-017-2047-8

Ejemplares similares